Screenshot 2024-05-03 at 4.10.31 PM
Craft.co Announces Five Year, $28 Million Contract with Secretary of the Air Force for Supplier Risk and Intelligence Technology
May 06, 2024 06:00 ET | Craft
SAN FRANCISCO, May 06, 2024 (GLOBE NEWSWIRE) -- Craft.co (www.craft.co), the supply chain resilience company, today announced a $28 million, five-year agreement with the Secretary of the Air Force...
Wave energy converter floats in Castine Harbor in Maine
Oscilla Power Successfully Launches Demonstration Scale TritonTM Wave Energy Converter (WEC) on Maine Coast
December 05, 2023 09:30 ET | Oscilla Power
A 1/6 scale of Oscilla Power's 1 MW wave energy converter was successfully deployed off the coast of Maine for a 12-week test.
Logo.png
Ocean Biomedical (NASDAQ: OCEA) Announces First Patients Dosed by Joint Venture Partner Virion Therapeutics in Phase 1b Study of Novel Immunotherapy for Chronic Hepatitis B Virus Infection
October 26, 2023 05:30 ET | Ocean Biomedical, Inc.
Providence, RI, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research...
tb_pressreleaselogo.png
Taglich Brothers Initiates Coverage of Ocean Biomedical, Inc.
May 31, 2023 09:30 ET | Taglich Brothers Inc
NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- Taglich Brothers, Inc. announces that it has initiated coverage of Ocean Biomedical, Inc. (NASDAQ: OCEA). Ocean Biomedical, Inc. headquartered in...
Picture1.png
Ocean Biomedical (NASDAQ: OCEA) Celebrates Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%
February 23, 2023 08:01 ET | Ocean Biomedical, Inc.
Providence, RI, Feb. 23, 2023 (GLOBE NEWSWIRE) -- As previously announced, Ocean Biomedical, Inc. (NASDAQ: OCEA) celebrates the discovery of bispecific antibodies that target Chitinase 3-like-1 and...
logo.jpg
Aesther and Ocean Biomedical Announce Shareholder Approval of Business Combination
February 06, 2023 09:15 ET | Aesther Healthcare Acquisition Corp.
NEW YORK and PROVIDENCE, R.I, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (“SPAC”) and Ocean Biomedical,...
Logo.jpg
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Preliminary Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc.
September 19, 2022 07:45 ET | Aesther Healthcare Acquisition Corp.
NEW YORK and PROVIDENCE, R.I., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (SPAC) and Ocean Biomedical,...